to treat people with small lymphocytic lymphoma (SLL) or chronic lymphocytic leukaemia (CLL) (SLL).
for the treatment of people with newly diagnosed acute myeloid leukaemia (AML) who are 75 years of age or older, or, in combination with azacitidine, decitabine, or low-dose cytarabine.
Just one more step!
Login first,to proceed further.
Send Enquiry